TherapeuticsMD Inc (TXMD)

5.46
AMEX : Health Care
Prev Close 5.62
Day Low/High 5.45 / 5.74
52 Wk Low/High 4.39 / 9.29
Avg Volume 3.46M
Exchange AMEX
Shares Outstanding 196.58M
Market Cap 1.10B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.

TherapeuticsMD Announces Publication Of Two Manuscripts On The Rejoice Trial For TX-004HR In Leading Peer-Reviewed Medical Journal

TherapeuticsMD Announces Publication Of Two Manuscripts On The Rejoice Trial For TX-004HR In Leading Peer-Reviewed Medical Journal

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced the publication of two manuscripts detailing results of the company's phase 3 Rejoice Trial in Menopause: The Journal of The...

Stocks Under $10 Weekly Summary

We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.

TherapeuticsMD Posts Strong Gains

TherapeuticsMD is up 9.7% in the first two trading days of 2017, and we're maintaining our $12.50 price target.

'Mad Money' Lightning Round: Jim Cramer Sees Opportunity in Sirius and Medtronic

'Mad Money' Lightning Round: Jim Cramer Sees Opportunity in Sirius and Medtronic

Sirius, Medtronic and Carlyle could be money makers in 2017, says Jim Cramer.

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.

TherapeuticsMD To Present At 35th Annual J.P. Morgan Healthcare Conference On January 11

TherapeuticsMD To Present At 35th Annual J.P. Morgan Healthcare Conference On January 11

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that the company will present at the 35 th Annual J.

Stocks Under $10 Weekly Summary

We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.

Stocks Under $10 Weekly Summary

We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.

Stocks Under $10 Weekly Summary

We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.

TherapeuticsMD Up on Fresh Buy Rating

Cantor Fitzgerald initiated coverage of the company overnight with $34 price target.

Buying More TherapeuticsMD

We'll put some money to work with TXMD and improve our cost basis.

TherapeuticsMD Announces Participation In 2016 BioFlorida Conference

TherapeuticsMD Announces Participation In 2016 BioFlorida Conference

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company headquartered in Boca Raton, announced the company's participation in the 2016 BioFlorida Conference to be held in Jacksonville from December...

Stocks Under $10 Weekly Summary

We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.

Adding to TherapeuticsMD on Weakness

TXMD reported positive clinical data earlier this week.

Jim Cramer's Top Takeaways: TherapeuticsMD, Pioneer Natural Resources

Jim Cramer's Top Takeaways: TherapeuticsMD, Pioneer Natural Resources

With a stock up 400%, what's not to like about Pioneer Natural Resources? Cramer says.

Jim Cramer's 'Mad Money' Recap: The Trump Rally Is Showing Cracks

Jim Cramer's 'Mad Money' Recap: The Trump Rally Is Showing Cracks

Stocks once considered free of risks aren't any longer, Cramer warns.

Positive Clinical Trial Lifts TherapeuticsMD

Stock soars after hours.

Figure 2. Mean Change From Baseline In Weekly Severity Of Moderate To Severe Hot Flashes For Weeks 1 To 12 (Graphic: Business Wire)

Figure 2. Mean Change From Baseline In Weekly Severity Of Moderate To Severe Hot Flashes For Weeks 1 To 12 (Graphic: Business Wire)

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced positive top-line results from its pivotal phase 3 Replenish Trial of TX-001HR, an investigational bio-identical hormone...

Stocks Under $10 Weekly Summary

We booked some profits in Huntington Bancshares and SLM this week and cut our rating on SLM from One to Two.

'Mad Money' Lightning Round: International Paper, Home Depot, Newell Brands

'Mad Money' Lightning Round: International Paper, Home Depot, Newell Brands

Jim Cramer prefers Newell over Berry Plastics and says International Paper is an inexpensive stock with a good yield.

Jim Cramer's 'Mad Money' Recap: This Rotation's Too Hard for the Bulls

Jim Cramer's 'Mad Money' Recap: This Rotation's Too Hard for the Bulls

Cramer wonders if this market has gotten too enthusiastic for the Trump agenda.

TherapeuticsMD's Weakness Is an Opportunity

Our research suggests the risk/reward potential is attractive at current levels.

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Charts showing up or down trends in the past week.

Analysts Like 3 Portfolio Names

Builders FirstSource, Huntington Bancshares and TherapeuticsMD all received upbeat outlooks from analysts overnight.

January 2017 Options Now Available For TherapeuticsMD (TXMD)

January 2017 Options Now Available For TherapeuticsMD (TXMD)

Investors in TherapeuticsMD, Inc. saw new options begin trading today, for the January 2017 expiration.

Stocks Under $10 Weekly Summary

We booked some profits in Synovus Financial and used part of the proceeds to buy more Yamana Gold.

Stocks Under $10 Weekly Summary

We sold the rest of our Datalink holdings and will use the proceeds to add a name to our portfolio.